(MENAFN - Grand View Research)

Latest Study by Grand View Research, Inc. titled Biologics Market Analysis By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi), By Disease Category, By Manufacturing, & Segment Forecasts, 2018 - 2025 announce that the global biologics market is anticipated to reach USD 399.5 billion by 2025, according to a new report by Grand View Research, Inc. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine anticipated to fuel demand. Ever-increasing understanding of the cell physiology and stress, as well as the factors involved in protein production and heterologous gene expression have empowered the use of different living factories.

Some key findings from the report:

These living factories are the prokaryotic and eukaryotic cells. Enhancement of drug functionality through achieving successful protein folding and post-translational modifications is supportive for projected progress rate.

Moreover, rising adoption of biopharmaceuticals over chemically synthesized molecules is expected to propel revenue generation significantly. In addition to this, presence of several metabolic disorders that can be treated through the use of biologics is attributive to influence demand.

Combination of advanced bioengineering technologies for biopharmaceutical production is expected to boost progress in pharmaceutical industry. With recent advances in automation, the selection process can be done through high throughput screening (HTS) system for selection of viable clones.

Aforementioned method enables robust production of biopharmaceutical products by obtaining high-producing cell line. Advances with respect to upstream and downstream processing would directly translate into the growth in revenue for this market at a larger level.

However, development of biosimilars is expected to restrain the biologics year on year growth to certain extent. Although, the regulatory approval pathway for these products is not framed yet some drug manufacturers are opting to invest in the development of biobetters.

For More Details Please Visit To This Link: https://www.grandviewresearch.com/industry-analysis/biologics-market/

The final report on global biologics market has been segmented on the basis of application and region:

Biologics Source Outlook (Revenue, USD Billion, 2014 - 2025)

Biologics Product Outlook (Revenue, USD Billion, 2014 - 2025)

Biologics Manufacturing Outlook (Revenue, USD Billion, 2014 - 2025)

Biologics Disease Category Outlook (Revenue, USD Billion, 2014 - 2025)

Biologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)

Get Sample of biologics market @ https://www.grandviewresearch.com/industry-analysis/biologics-market/request/rs1/

Media Contact

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

MENAFN1012201900702939ID1099403669

Read the rest here:

Biologics Market Size Expand at a CAGR of 3.9 With $399.5 Billion By 2025 - MENAFN.COM